TEVA PHARMS USA FDA Approval ANDA 206020

ANDA 206020

TEVA PHARMS USA

FDA Drug Application

Application #206020

Documents

Letter2018-08-20

Application Sponsors

ANDA 206020TEVA PHARMS USA

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2018-07-10STANDARD

Submissions Property Types

ORIG1Null1

CDER Filings

TEVA PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206020
            [companyName] => TEVA PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"SAXAGLIPTIN","activeIngredients":"SAXAGLIPTIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/10\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/206020Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-07-10
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.